Next Article in Journal
Crellasterones A and B: A-Norsterol Derivatives from the New Caledonian Sponge Crella incrustans
Next Article in Special Issue
Design, Synthesis, and Antifouling Activity of Glucosamine-Based Isocyanides
Previous Article in Journal
Marine Sponges and Bacteria as Challenging Sources of Enzyme Inhibitors for Pharmacological Applications
Article Menu
Issue 6 (June) cover image

Export Article

Open AccessReview

Off the Shelf Fouling Management

Nicholas School of the Environment, Duke University, Durham, NC 27708, USA
Mar. Drugs 2017, 15(6), 176;
Received: 6 May 2017 / Revised: 31 May 2017 / Accepted: 8 June 2017 / Published: 14 June 2017
(This article belongs to the Special Issue Antifouling Marine Natural Products)
PDF [1385 KB, uploaded 14 June 2017]


This chapter tells the story of a research thread that identified and modified a pharmaceutical that could be a component of environmentally benign fouling management coatings. First, I present the background context of biofouling and how fouling is managed. The major target of the research is disrupting transduction of a complex process in all macrofouling organisms: metamorphosis. Using a bioassay directed approach we first identified a pharmaceutical candidate. Then, based on structure function studies coupled with laboratory and field bioassays, we simplified the molecule, eliminating halogens and aromatic rings to a pharmacophore that could be readily broken down by bacteria. Next, we did further structure function studies coupled to lab and field bioassays of modifications that enabled delivery of the molecule in a variety of coatings. The outcome is a different way of thinking about managing fouling and concepts in which molecules are designed to perform a function and then degrade. This work is discussed in the context of existing fouling management approaches and business models which use long-lived broad-spectrum biocides which have consequences for human, environmental health, and food security. View Full-Text
Keywords: pharmaceuticals; fouling management; evolutionary principles; conserved pathways; metamorphosis; business models pharmaceuticals; fouling management; evolutionary principles; conserved pathways; metamorphosis; business models

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Rittschof, D. Off the Shelf Fouling Management. Mar. Drugs 2017, 15, 176.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top